Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in Lithuania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: Lithuania Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20031
20042
20052
20061
20071
20084
20096
20103
20113
20124
20131
20143
20152
20161
20171
20183
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Terminated11
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi9
Takeda7
AstraZeneca4
Boehringer Ingelheim3
Eli Lilly and Company3
Bayer2
Forest Laboratories2
GlaxoSmithKline2
Hoffmann-La Roche2
Janssen Research & Development, LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 242
Diabetes Mellitus8
Cardiovascular Diseases5
Diabetic Nephropathies3
Glucose Metabolism Disorders3
Hyperglycemia3
Renal Insufficiency, Chronic3
Dyslipidemias2
Glucose Intolerance2
Heart Failure2

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.